Evidence map›Paper›PMID 17675387›Full record

ArticleJournal of bacteriology2007

Generation of virulence factor variants in Staphylococcus aureus biofilms.

Jeremy M Yarwood, Kara M Paquette, Ilya B Tikh, Esther M Volper, E Peter Greenberg

Abstract read
In one paragraph

Article in Journal of bacteriology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Article
  2. Microorganisms · 2025
    Review
  3. The ability ofInfection and immunity · 2025
    Article
  4. Microorganisms · 2025
    Article
  5. Community-Acquired Methicillin-ResistantDiagnostics (Basel, Switzerland) · 2023
    Article
  6. Article
  7. The promising anti-virulence activity of candesartan, domperidone, and miconazole on Staphylococcus aureus.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2022
    Article
  8. Article
  9. Article
  10. Clinically Approved Drugs Inhibit theFrontiers in microbiology · 2019
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Experimental evolution in biofilm populations.FEMS microbiology reviews · 2016
    Review
  16. Review
  17. Identification and Characterization of anFrontiers in microbiology · 2016
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jeremy M Yarwood3M Corporate Research Laboratories, 3M Center, Bldg. 201-3E-03, St. Paul, MN 55144, USA. jyarwood@mmm.com
Kara M Paquette
Ilya B Tikh
Esther M Volper
E Peter Greenberg

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several serious diseases are caused by biofilm-associated Staphylococcus aureus. Colonial variants occur in biofilms of other bacterial species, and S. aureus variants are frequently isolated from biofilm-associated infections. Thus, we studied the generation of variants with altered expression of virulence factors in S. aureus biofilms. We observed that the number of variants found in biofilms, as measured by hemolytic activity, varied for different strains. Further study of hemolytic activity and signaling by the accessory gene regulator (Agr) quorum-sensing system in one S. aureus strain revealed three primary biofilm subpopulations: nonhemolytic (Agr deficient), hemolytic (Agr positive), and hyperhemolytic (also Agr positive). The nonhemolytic variant became the numerically dominant subpopulation in the biofilm. The nonhemolytic variant phenotype was stable and heritable, indicating a genetic perturbation, whereas the hyperhemolytic phenotype was unstable, suggesting a phase variation. Transcription profiling revealed that expression of the agr locus and many extracellular virulence factors was repressed in the nonhemolytic variant. Expression of the agr-activating gene, sarU, was also repressed in the nonhemolytic variant, suggesting one potential regulatory pathway responsible for the Agr-deficient phenotype. We suggest that the development of these variants in biofilms may have important clinical implications.

Indexed as

BiofilmsGenetic VariationBacterial ProteinsGene Expression Regulation, BacterialHemolysisSignal TransductionStaphylococcus aureusTrans-ActivatorsVirulence FactorsAgr protein, Staphylococcus aureusBacterial ProteinsTrans-ActivatorsVirulence Factors

Identifiers

PMID17675387
PMCPMC2168666

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.